Therefore, diagnosis and therapy, which target EMT-TFs, including those of the Snail and ZEB families, will require the development of methods that can recognize both proteins simultaneously as well as anti-tumor drugs that can target both proteins simultaneously. This evidence concerns the gene ZEB1 and neoplasm.